Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px

News > All

Total search results: 16855 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 167 168 169  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Roivant Sciences GmbH. (11/13/18). "Press Release: Roivant Sciences Announces $200 Million Investment Round". Basel & London. 2018-11-13
bioMérieux S.A.. (11/13/18). "Press Release: bioMérieux Launches the BioFire FilmArray Pneumonia Panels with FDA Clearance and CE Marking". Marcy l’Étoile. 2018-11-13
Compugen Ltd.. (11/13/18). "Press Release: Compugen Announces Issuance of U.S. Patent for COM902, Its TIGIT Antibody Product Candidate for Cancer Immunotherapy". Holon. 2018-11-13
Evotec AG. (11/13/18). "Press Release: Evotec AG Reports First Nine-months 2018 Results and Corporate Updates". Hamburg. 2018-11-13
Hox Therapeutics Ltd.. (11/13/18). "Press Release: Hox Therapeutics Appoints Karl Keegan as Chief Executive Officer". Guildford, Surrey. 2018-11-13
Merck KGaA. (11/12/18). "Press Release: Merck Paves the Way for Its Innovation Hub in Southern China". Darmstadt & Guangzhou. 2018-11-12
Amal Therapeutics S.A.. (11/12/18). "Press Release: Amal Therapeutics Finalises €29 Million (CHF 33.2 Million) Series B Round". Geneva. 2018-11-12
Mologen AG. (11/12/18). "Press Release: Lefitolimod – First Clinical Data in Combination with a Checkpoint Inhibitor and further Preclinical Results Presented at SITC 2018". Berlin. 2018-11-12
IntegraGen S.A.. (11/12/18). "Press Release: IntegraGen Announces Collaboration with Google Cloud to Offer Large Scale Genomic Analysis Tools for Clinicians and Medical Researchers". Paris. 2018-11-12
Life Sciences Partners (LSP). (11/12/18). "Press Release: LSP Raises Record €750 Million in 10 Months for Life Sciences Innovations [NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY JURISDICTION WHERE U 2018-11-12
Quantum Genomics S.A.. (11/12/18). "Press Release: Quantum Genomics Announces Excellent Topline Results from Phase 2b NEW-HOPE Study Evaluating Firibastat for Arterial Hypertension". Paris & New York, NY. 2018-11-12
Medigene AG. (11/12/18). "Press Release: Medigene Reports Financial & Business Results for the First Nine Months of 2018". Planegg. 2018-11-12
Medigene AG. (11/12/18). "Press Release: Medigene Signs Exclusive License Agreement with Leiden University to Develop Novel T Cell Receptor". Martinsried. 2018-11-12
Consilium Strategic Communications Ltd.. (11/12/18). "Press Release: Alex Harrison Joins Consilium Strategic Communications". London. 2018-11-12
Aimmune Therapeutics, Inc.. (11/12/18). "Press Release: Aimmune Therapeutics Announces Additional Equity Investment by Nestlé Health Science". Brisbane, CA. 2018-11-12
CRISPR Therapeutics AG. (11/9/18). "Press Release: CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology". Zug, Cambridge, MA & Gaithersburg, MD. 2018-11-09
Scienion AG. (11/9/18). "Press Release: R2R Biofluidics EU Project Recently Received the Austrian Fast Forward Award 2018". Berlin. 2018-11-09
bioMérieux S.A.. (11/9/18). "Press Release: bioMérieux Acquires a Majority Stake in Hybiome and Strengthens Its Presence Both in China and in the Immunoassay Market". Marcy l’Étoile. 2018-11-09
Arsanis, Inc.. (11/9/18). "Press Release: Arsanis Reports Financial Results for Third Quarter 2018". Waltham, MA & Vienna. 2018-11-09
Edinburgh Molecular Imaging Ltd.. (11/8/18). "Press Release: Edinburgh Molecular Imaging Appoints Bernhard Sixt as New Chief Executive Officer". Edinburgh. 2018-11-08
Themis Bioscience N.V.. (11/8/18). "Press Release: Themis Bioscience Postpones Its Listing on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna. 2018-11-08
Convert Pharmaceuticals S.A.. (11/8/18). "Press Release: Convert Pharmaceuticals Appoints Mariola Söhngen as New CEO". 2018-11-08
Denali Therapeutics Inc.. (11/8/18). "Press Release: Denali Therapeutics Reports Third Quarter 2018 Financial Results and Business Highlights and Announces the Appointment of Jennifer Cook to Board of Directors". South San Francisco, CA. 2018-11-08
InflaRx N.V.. (11/8/18). "Press Release: InflaRx Completes Enrollment in Phase IIb Clinical Trial with Lead Candidate IFX-1 in Hidradenitis Suppurativa". Jena. 2018-11-08
Mologen AG. (11/8/18). "Press Release: Implementation of Financing Measures and Publication of Study Results". Berlin. 2018-11-08
CRISPR Therapeutics AG. (11/7/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2018 Financial Results". Zug & Cambridge, MA. 2018-11-07
Bone Therapeutics S.A.. (11/7/18). "Press Release: Bone Therapeutics Business Update for Third Quarter 2018". Gosselies. 2018-11-07
Compugen Ltd.. (11/7/18). "Press Release: Compugen Reports Third Quarter 2018 Results". Holon. 2018-11-07
Curetis N.V.. (11/7/18). "Press Release: Curetis Raises €8.9 Million through Private Placements [Not for United States, Australia, Canada, Japan or South Africa or any other Jurisdiction where unlawful]". Amsterdam, Holzgerlingen & San Diego, CA. 2018-11-07
Genomics Medicine Ireland Ltd.. (11/7/18). "Press Release: GMI Genomics Centre Awarded CAP-Accreditation". 2018-11-07
Genomics Medicine Ireland Ltd.. (11/6/18). "Press Release: GMI Appoints Dr. Anne Jones as CEO". 2018-11-06
Bone Therapeutics S.A.. (11/6/18). "Press Release: Bone Therapeutics Announces Conclusions from Interim Analysis of Phase III PREOB Study in Hip Osteonecrosis". Gosselies. 2018-11-06
ProBioGen AG. (11/6/18). "Press Release: ProBioGen Announces Successful Bispecific GlymaxX Development Project for Zymeworks". Berlin. 2018-11-06
Spark Therapeutics, Inc.. (11/6/18). "Press Release: Spark Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Progress". Philadeliphia, PA. 2018-11-06
AstraZeneca plc. (11/6/18). "Press Release: Divestment of Rights to Alvesco, Omnaris and Zetonna to Covis Pharma". 2018-11-06
Genedata AG. (11/6/18). "Press Release: Sartorius Stedim Cellca Licenses Genedata Bioprocess to Streamline Development Operations". Basel. 2018-11-06
Marinomed Biotech AG. (11/5/18). "Press Release: Marinomed Announces Its Intention to Launch an Initial Public Offering and Listing on the Vienna Stock Exchange [Not for US, AU, CA, JP, et al.]". Vienna. 2018-11-05
MorphoSys AG. (11/5/18). "Press Release: MorphoSys AG Announces Third Quarter 2018 Results". Planegg. 2018-11-05
Orchard Therapeutics Ltd.. (11/5/18). "Press Release: Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters’ Option". Boston, MA & London. 2018-11-05
BioNTech AG. (11/5/18). "Press Release: BioNTech and the University of Pennsylvania Enter into Strategic Research Collaboration to Develop mRNA Vaccine Candidates against Various Infectious Diseases". Mainz. 2018-11-05
Themis Bioscience GmbH. (11/5/18). "Press Release: Themis Bioscience Publishes Compelling Phase 2 Results for Lead Vaccine Candidate against Chikungunya Fever in The Lancet". Vienna. 2018-11-05
Boehringer Ingelheim. (11/5/18). "Press Release: Initial Results from EMPRISE Real-world Evidence Study". Ingelheim & Indianapolis, IN. 2018-11-05
Immunic AG. (11/5/18). "Press Release: Immunic Enters into a Global Option and License Agreement with Daiichi Sankyo". Planegg-Martinsried. 2018-11-05
Curetis N.V.. (11/2/18). "Press Release: Curetis Launches Privately Placed Capital Increase to Raise up to €18.4 Million [NOT FOR THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL]". Amsterdam, Hol 2018-11-02
Omeicos Therapeutics GmbH. (11/2/18). "Press Release: Omeicos Therapeutics Closes €17m Series C Financing to Advance Lead Candidate OMT-28 Towards Pivotal Trials in Atrial Fibrillation". Berlin & Boston, MA. 2018-11-02
Centogene AG. (11/2/18). "Press Release: Centogene Further Expands Executive Team, Appoints Oved Amitay as Chief Business Officer – Increases Focus on Pharma Partnerships". Rostock. 2018-11-02
Cristal Delivery B.V. (d/b/a Cristal Therapeutics). (11/2/18). "Press Release: Dr. Axel Mescheder Appointed CEO of Cristal Therapeutics as Focus Intensifies on Proprietary Oncology Nanomedicine Pipeline". Maastricht. 2018-11-02
Illumina, Inc.. (11/1/18). "Press Release: Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery". Sam Diego, CA & Menlo Park, CA. 2018-11-01
Sanofi S.A.. (11/1/18). "Press Release: Sanofi and Denali Therapeutics to Develop Treatments for Neurological and Inflammatory Diseases". Paris. 2018-11-01
Denali Therapeutics Inc.. (11/1/18). "Press Release: Denali Therapeutics Announces Broad Collaboration with Sanofi to Develop RIPK1 Inhibitors for the Treatment of Neurological and Inflammatory Diseases". South San Francisco, CA. 2018-11-01
Argen-X N.V. (Argenx). (11/1/18). "Press Release: Argenx Announces New Cusatuzumab (ARGX-110) AML Data in Abstracts Published in Connection with 60th American Society of Hematology Annual Meeting and Exposition". Breda & Ghent. 2018-11-01
Allogene Therapeutics, Inc.. (11/1/18). "Press Release: Allogene Therapeutics Announces Data Presentations Supporting Its Allogeneic CAR T Pipeline Program at 60th American Society of Hematology (ASH) Annual Meeting". South San Francisco, CA. 2018-11-01
Boehringer Ingelheim. (10/31/18). "Press Release: Boehringer Ingelheim Achieves Next Expansion Milestone in Biologics Production in the US". Fremont, CA. 2018-10-31
PerkinElmer, Inc.. (10/31/18). "Press Release: PerkinElmer Announces Financial Results for the Third Quarter of 2018". Waltham, MA. 2018-10-31
[iito] Business Intelligence. (10/31/18). "Press Release: [iito] Discontinues Life-Sciences-Spain.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. 2018-10-31
Sanofi S.A.. (10/31/18). "Press Release: Sanofi Q3 2018 Performance Confirms Return to Growth". Paris. 2018-10-31
Cobra Biologics Ltd.. (10/30/18). "Press Release: Cobra Biologics and the University of Leeds Collaborate in BioProNET Funded Project". Keele & Leeds. 2018-10-30
Grünenthal GmbH. (10/30/18). "Press Release: Grünenthal Agrees US$ 922 m Deal with AstraZeneca for Nexium and Vimovo". Aachen. 2018-10-30
BioM Biotech Cluster Development GmbH. (10/30/18). "Pressemitteilung: BioM erhält Auftrag zur Projektkoordination von »DigiMed Bayern«. Bayerisches Gesundheitsministerium fördert das medizinische Digitalisierungsvorhaben mit 20 Millionen Euro über 5 Jahr 2018-10-30
DefiniGen Ltd.. (10/30/18). "Press Release: DefiniGen Licenses Broad Institute CRISPR-Cas9 Gene Editing Technology for Optimized Metabolic Disease Drug Development". Cambridge. 2018-10-30
Newron Pharmaceuticals S.p.A.. (10/30/18). "Press Release: Investment Plan for Europe. EIB Backs Italian CNS Drug Developer Newron Pharmaceuticals with up to EUR 40m". Luxembourg & Milan. 2018-10-30
Bone Therapeutics S.A.. (10/29/18). "Press Release: Bone Therapeutics Announces Appointment of Linda Lebon as Chief Regulatory Officer". Gosselies. 2018-10-29
Edinburgh Molecular Imaging Ltd.. (10/29/18). "Press Release: Edinburgh Molecular Imaging Ltd Appoints New Chairman". Edinburgh. 2018-10-29
Themis Bioscience N.V.. (10/29/18). "Press Release: Themis Bioscience Launches its Initial Public Offering on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna. 2018-10-29
ProQR Therapeutics N.V.. (10/29/18). "Press Release: ProQR In-licenses Worldwide Rights to Ophthalmology Drug Candidate from Ionis Pharmaceuticals". Leiden. 2018-10-29
Noscendo GmbH. (10/29/18). "Press Release: Noscendo Closes Financing Round for CE Certification and Market Entry Preparation of Platform Diagnostics for Bloodstream Associated Infections". Duisburg. 2018-10-29
Thermo Fisher Scientific Inc.. (10/29/18). "Press Release: Thermo Fisher Scientific Announces Collaboration to Simplify Analysis of Complex Therapeutic Proteins". Sunnyvale, CA. 2018-10-29
Galecto Biotech AB. (10/26/18). "Press Release: Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development". Copenhagen. 2018-10-26
Boehringer Ingelheim. (10/26/18). "Press Release: Boehringer Ingelheim Inaugurates New Centre for Agile Working Methods – More and Better Health Solutions for Humans and Animals". Ingelheim. 2018-10-26
Oryzon Genomics S.A.. (10/26/18). "Press Release: Oryzon Raises EUR 13 Million through a Private Placement with US and European Investors [Not for US, CA, AU, JP, ZA or any other jurisdiction where unlawful]". Madrid & Cambridge, MA. 2018-10-26
Immunocore Ltd.. (10/26/18). "Press Release: Immunocore CEO Andrew Hotchkiss Appointed to the Board of the BIA". Oxford & Conshohocken, PA. 2018-10-26
Gamida Cell Ltd.. (10/26/18). "Press Release: Gamida Cell Announces Pricing of Initial Public Offering". Boston, MA. 2018-10-26
Euformatics Oy. (10/25/18). "Press Release: Euformatics Selected for GEMMA H2020 Project to Provide Genomics Analysis and Quality Control for Autism Spectrum Disorders". Espoo. 2018-10-25
Milestone Pharmaceuticals Inc.. (10/25/18). "Press Release: Milestone Pharmaceuticals Announces $80 Million Private Financing". Montréal, QC & Charlotte, NC. 2018-10-25
H. Lundbeck A/S. (10/25/18). "Press Release: Lundbeck Updates on Clinical Phase III Study for Lu AF35700 in Treatment-Resistant Schizophrenia". Valby. 2018-10-25
Zelluna Immunotherapy AS. (10/24/18). "Press Release: Zelluna Immunotherapy Appoints Geir Christian Melen as Chief Financial Officer". Oslo. 2018-10-24
Thermo Fisher Scientific Inc.. (10/24/18). "Press Release: Thermo Fisher Scientific Reports Third Quarter 2018 Results". Waltham, MA. 2018-10-24
Orexo AB. (10/24/18). "Press Release: Orexo Appoints Joseph DeFeo as New CFO". Uppsala. 2018-10-24
BASF SE. (10/24/18). "Press Release: BASF Licenses CRISPR-Cpf1 Genome Editing Technology from the Broad Institute of MIT and Harvard". Research Triangle Park, NC. 2018-10-24
Apitope International N.V.. (10/24/18). "Press Release: Apitope Announces Management Changes. Keith Martin to Retire as CEO, Continue as Non-Executive Director – Hayley French Appointed COO and Interim CEO". Hasselt & Chepstow. 2018-10-24
Microbiotica Ltd.. (10/24/18). "Press Release: Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital Fund". Cambridge. 2018-10-24
Magnisense SE. (10/24/18). "Press Release: Magnisense Successfully Raises € 5 Nillion to Boost the Commercial Development of Its MiAG Emergency Diagnostic Tests for Heart Diseases". Paris. 2018-10-24
Intrexon Corporation. (10/24/18). "Press Release: Intrexon Announces the Formation of Bioinformatics Hub in Munich. Establishing itself as Intrexon Bioinformatics Germany GmbH (IBG)". Germantown, MD. 2018-10-24
NodThera Ltd.. (10/23/18). "Press Release: NodThera Announces the Appointment of Alison Strutt PhD as Head of Finance & Operations, the Launch of Its New Corporate Office in Boston and the Opening of Its Laboratory in Seattle". Cambridge, Boston, MA & Se 2018-10-23
Hybrigenics S.A.. (10/23/18). "Press Release: Clinical Study of Inecalcitol in Acute Myeloid Leukemia Stopped for Futility. The Clinical Development of Inecalcitol Is Discontinued". Paris. 2018-10-23
Idorsia Ltd.. (10/23/18). "Press Release: Idorsia Announces that Simon Jose Is to Join the Company as Chief Commercial Officer". Alschwil. 2018-10-23
Enterome S.A.. (10/23/18). "Press Release: Enterome Signs Global Licensing, Co-development and Co-Promotion Agreement with Takeda for the Treatment of Crohn’s Disease". Paris & Cambridge, MA. 2018-10-23
Innate Pharma S.A.. (10/23/18). "Press Release: Innate Pharma Strengthens and Expands Its Oncology Development Collaboration with AstraZeneca". Marseille. 2018-10-23
Novartis AG. (10/23/18). "Press Release: Alcon to Develop SMART Suite Digital Health Platform for Cataract Surgery". Fort Worth, TX. 2018-10-23
H. Lundbeck A/S. (10/22/18). "Press Release: U.S. Food and Drug Administration Approves Expansion of Trintellix (vortioxetine) Label". Valby. 2018-10-22
Glycotest Inc.. (10/22/18). "Press Release: Glycotest Inc. Closes $10 Million Series A Financing". New York. 2018-10-22
Medicines Discovery Catapult, The. (10/22/18). "Press Release: Overcoming Bottlenecks in Early Drug Discovery with the Power of Sound. Medicines Discovery Catapult and AstraZeneca Collaborate to Unlock the Potential of Acoustic Mist Ionisation Mass Spect 2018-10-22
Validogen GmbH. (10/22/18). "Press Release: Change of Company Name – VTU Technology Is Now Validogen". Raaba-Grambach. 2018-10-22
Boehringer Ingelheim. (10/19/18). "Press Release: Real-world Study Shows Using Giotrif/Gilotrif (afatinib) Followed by Osimertinib Provides a Median of 27.6 Months of Chemotherapy-free Time in Patients with EGFR Mutation-positive NSCLC". Ingelheim. 2018-10-19
Marinomed Biotech AG. (10/19/18). "Press Release: Initiation of First Marinosolv Clinical Trial (Ph III)". 2018-10-19
Apceth Biopharma GmbH. (10/19/18). "Press Release: Apceth Biopharma Presents Positive Data Demonstrating Efficacy of Apceth-201 in Preclinical Models of Acute GvHD". Munich. 2018-10-19
Aelix Therapeutics S.L.. (10/18/18). "Press Release: Aelix Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure". 2018-10-18
MaSTherCell S.A.. (10/18/18). "Press Release: Iovance Biotherapeutics and MaSTherCell Announce New Manufacturing Services Agreement in Europe". San Carlos, CA & Gosselies. 2018-10-18
Novartis AG. (10/18/18). "Press Release: Novartis Delivered Strong Growth and Innovation During the Third Quarter, Including Progressing Advanced Therapy Platforms to Drive Future growth". Basel. 2018-10-18
Amgen Inc.. (10/18/18). "Press Release: Amgen Invests £50 Million ($66 Million) in Oxford Nanopore Technologies". Thousand Oaks, CA & Oxford. 2018-10-18
next pagenext page 1 2 3 ... 167 168 169  next pagenext page



Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top